Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 1.94%
- Poor long term growth as Operating profit has grown by an annual rate 2.88% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.16
Risky - Negative Operating Profits
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Miscellaneous
INR 87 Cr (Micro Cap)
NA (Loss Making)
49
0.00%
0.13
-3.87%
1.00
Total Returns (Price + Dividend) 
Latest dividend: 0.01 per share ex-dividend date: Sep-23-2014
Risk Adjusted Returns v/s 
Returns Beta
News

Sundaram Multi Pap Falls to 52-Week Low of Rs.1.61 Amidst Continued Downtrend
Sundaram Multi Pap has reached a new 52-week low of Rs.1.61 today, marking a significant decline amid a persistent downward trend. The stock has recorded losses over the past five consecutive sessions, reflecting ongoing pressures within the miscellaneous sector despite a broadly positive market environment.
Read More
Sundaram Multi Pap Falls to 52-Week Low of Rs.1.61 Amid Continued Downtrend
Sundaram Multi Pap has reached a new 52-week low of Rs.1.61, marking a significant decline as the stock continues its downward trajectory. This fresh low comes amid a series of losses over the past week, reflecting ongoing pressures within the miscellaneous sector.
Read More
Sundaram Multi Pap Stock Falls to 52-Week Low of Rs.1.61 Amidst Continued Downtrend
Sundaram Multi Pap has reached a new 52-week low of Rs.1.61 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past five consecutive sessions, reflecting ongoing pressures within the company’s financial performance and market positioning.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-Nov-2025 | Source : BSENewspaper advertisement of unaudited standalone Financial result for the quarter and half year ended on September 30 2025 is attached herewith.
Outcome Of Board Meeting Held On November 13 2025
13-Nov-2025 | Source : BSEFinancial Results for the quarter ended on September 30 2025 is attached herewith.
Board Meeting Outcome for Outcome Of Board Meeting Held On November 13 2025
13-Nov-2025 | Source : BSEUnaudited Standalone Financial Result for the quarter and half year ended as on September 30 2025 is attached herewith.
Corporate Actions 
No Upcoming Board Meetings
Sundaram Multi Pap Ltd has declared 1% dividend, ex-date: 23 Sep 14
No Splits history available
Sundaram Multi Pap Ltd has announced 2:1 bonus issue, ex-date: 13 Apr 12
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
2.2192
Held by 0 Schemes
Held by 0 FIIs
Yash Raichand Shah (9.94%)
Vyoman India Private Limited (2.88%)
60.25%
Quarterly Results Snapshot (Standalone) - Sep'25 - YoY
YoY Growth in quarter ended Sep 2025 is 8.46% vs 7.62% in Sep 2024
YoY Growth in quarter ended Sep 2025 is 145.36% vs 22.13% in Sep 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.41% vs 2.83% in Sep 2024
Growth in half year ended Sep 2025 is 124.68% vs 50.31% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is 1.44% vs 17.95% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 19.74% vs -244.96% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 0.30% vs 11.09% in Mar 2024
YoY Growth in year ended Mar 2025 is -0.79% vs -296.14% in Mar 2024






